10 Small Caps Growing 100%+

Investors are wary right now. That means there are small companies with tremendous upside and growth potential... trading at huge discounts.‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌  [Profit Trends]( [Making the Grade](  10 Small Caps With Triple-Digit Revenue Growth Matthew Carr | Chief Trends Strategist | The Oxford Club  [101 Easy Ways to Generate a Lifetime of Income]( [Best Book of Retirement Secrets](No matter your age or net worth, you can have the kind of retirement you want and deserve! "The Best Damn Book of Retirement Secrets" is the newest release from national bestselling author Marc Lichtenfeld... and it's chock-full of 101 proven strategies for getting every retirement advantage you need for the retirement of your dreams. We're giving away 500 FREE COPIES today. [>>CLICK HERE TO CLAIM YOUR FREE COPY<<](  [Matthew Carr] This year, the Dow Jones Industrial Average, the Nasdaq Composite and S&P 500 all hit new all-time highs. And they didn't do so just once. They notched new records more than 20 times. Despite concerns swirling around the U.S.-China trade war, bond yield inversions and slowing global growth, U.S. equities couldn't be stopped. But 2019 hasn't been a breakout year for everyone. In fact, there's one group of companies that's failing to keep up. I'm talking about small caps. Traditionally, during periods of international uncertainty, these have been favorites among investors. That's because they're seen as bets on the domestic economy, not the global one. But investors are wary right now. That creates a situation where we have small companies with tremendous upside and growth potential... trading at huge discounts. And there are some very attractive names worth looking into in the small cap space. 10 Small Caps to Watch Year to date, the Russell 2000 small cap index has trailed its larger brethren...  [Chart - Broader Markets - Year to Date]  But to say small caps have been punished in 2019 is far from accurate. For those looking for value and growth, there's a lot to like about the 2020 prospects. The Russell 2000's 52-week high of 1,618.37 was set back in May. And small caps are currently trading 8.5% below their all-time high of 1,742.09, set more than a year ago in August 2018. They've been in this drawn-out correction that they're still recovering from. But there's more to this underperformance in 2019 than merely a couple of percentage points. Of course, first and foremost, if small caps are lagging, it demonstrates that investors are looking for safety. They're shedding smaller names. And they're looking to park their money in larger, more stable companies (often dividend-paying ones). Which means there are plenty of fast-growing small caps that are on sale right now. Keeping an eye on 2020, let's look at 10 small caps that are expected to see revenue grow 100% or more next year!  [10 Small Caps Growing Revenue at Least 100%]  As we can see, some of these small cap darlings are poised to see enormous upswings in sales. And a lot of that has to do with what I discussed in last week's [Making the Grade]( about the explosive potential of biotechs. Way out in front is the biopharmaceutical Immunomedics (Nasdaq: IMMU). The company focuses on monoclonal antibody-based products to treat cancer. Shares are currently trading more than 17% below their 52-week high. And business is about to go into hyperdrive. In 2020, revenue is projected to skyrocket 8,207.9% to $63.14 million!  [Bill O'Reilly's Wild Money Secret](  [Bill O'Reilly Video Thumbnail](  [In a tell-all video, Bill O'Reilly reveals the shocking way YOU can retire with a seven-figure nest egg.](  That's more than three times larger than the second-highest increase on our list, belonging to Zogenix (Nasdaq: ZGNX). Zogenix is expected to see 2020 sales surge 2,663.3%. It should probably come as no surprise that this is also a pharmaceutical company. Though it specializes in treating central nervous system disorders. Shares also nearly 20% below their 52-week highs. We then have The Medicines Company (Nasdaq: MDCO). Revenue for this biopharmaceutical is projected to soar 2,617.3% to $33.15 million. And shares are currently trading just below their 52-week high. But looking at this list of booming 2020 revenue growers, you've likely noticed a trend. We have names like BridgeBio Pharma (Nasdaq: BBIO), Sage Therapeutics (Nasdaq: SAGE), Ra Pharmaceuticals (Nasdaq: RARX) and China's Zai Lab Ltd. (Nasdaq: ZLAB). These are all from the same fast-growing sector: biotech. But what about the other three? Two of the remaining companies are from the energy sector. There's the infrastructure company New Fortress Energy (Nasdaq: NFE), which is projected to see revenue grow 278.6% to $793.32 million. And there's the liquefied natural gas shipper Tellurian (Nasdaq: TELL). Its revenue is expected to jump nearly 450% to $158.89 million next year. The third is an interesting one: GSX Techedu (NYSE: GSX). This is a Chinese company that offers online K-12 after-school tutoring. It also offers personal interest courses such as calligraphy, guitar and yoga. With education being such a priority in China, business for GSX is blasting off. Revenue should increase at least 158% in 2020 to $731.94 million. High Growth on Sale Small caps are some of my favorite companies to trade. They offer substantial upside and can break out exceptionally fast. Though you always want to make sure you're keeping that small cap price premium in check. That's why I'm always looking for small caps that have had recently pulled back or dipped. Because I want to buy high growth at a discount. Here's to high returns, Matthew   [Leave a Comment](  [Facebook]( [Twitter]( [Share](mailto:?subject=A%20great%20piece%20from%20Profit%20Trends...&body=From%20Profit%20Trends:%0D%0A%0D%0A Investors%20are%20wary%20right%20now.%20That%20means%20there%20are%20small%20companies%20with%20tremendous%20upside%20and%20growth%20potential...%20trading%20at%20huge%20discounts. %0D%0A%0D ?src=shared) [Marijuana on Coins]( [American Multistate Operators Report Earnings This Week]( Matthew Carr | November 18, 2019 Warren Buffett famously advises, "Be fearful when others are greedy, and greedy when others are fearful." [Read More](  [Vaping]( [Latest Vaping News: Where Did We Go Wrong?]( Matthew Carr | November 14, 2019 Our two legislative expert guests break down how the government failed consumers during the recent vaping crisis. [Read More](  [Oil Field Workers]( [Conventional Oil and Gas Discoveries Hit 70-Year Lows]( David Fessler | November 13, 2019 Over the last three years, new oil discoveries hit a 70-year low... with no indication of a rebound. [Read More](  [Do You Own ANY 5G Stocks?]( [5G Design Graphic](CNN calls 5G "the lifeblood of the new economy." If you don't invest now, you'll regret it later. [Click here for details on the top 5G stock...](   You are receiving this email because you subscribed to Profit Trends. To unsubscribe from Profit Trends, [click here]( ). Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. To cancel by mail or for any other subscription issues, write us at: Profit Trends | Attn: Member Services | 105 West Monument Street | Baltimore, MD 21201 North America: [1.800.589.3430]( | International: [+1.443.353.4334]( | Fax: [1.410.329.1923]( Website: [profittrends.com]( Keep the emails you value from falling into your spam folder. [Whitelist Profit Trends](. © 2019 The Oxford Club LLC All Rights Reserved  [Oxford Club] The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201. Â